Cholecystokinin-dopamine intearctions

New peptide in the vertebrate CNS reacting with antigastrin antibodies

1975 • 749 citations

Cholecystokinin potentiates dopamine-mediated behaviors: evidence for modulation specific to a site of coexistence

1985 • 166 citations

Cholecystokinin potentiates dopamine-mediated behaviors: evidence for modulation specific to a site of coexistence.

1985 • 165 citations

Activity of A9 and A10 dopaminergic neurons in unrestrained rats: further characterization and effects of apomorphine and cholecystokinin

1987 • 164 citations

Autoradiographical detection of cholecystokinin-A receptors in primate brain using 125I-Bolton Hunter CCK-8 and 3H-MK-329

1990 • 155 citations

Cholecystokinin Modulates the Release of Dopamine from the Anterior and Posterior Nucleus Accumbens by Two Different Mechanisms

1991 • 150 citations

Neuronal Cholecystokinin

1986 • 144 citations

Interactions of cholecystokinin octapeptide and dopamine on nucleus accumbens neurons

1984 • 137 citations

CCK-8-immunoreactivity distribution in human brain: selective decrease in the substantia nigra from parkinsonian patients

1982 • 106 citations

Topographical analysis of nucleus accumbens sites at which cholecystokinin potentiates dopamine-induced hyperlocomotion in the rat

1985 • 97 citations

Cholecystokinin-dopamine coexistence: electrophysiological actions corresponding to cholecystokinin receptor subtype

1986 • 93 citations

Increase in brain 125I-cholecystokinin (CCK) receptor binding following chronic haloperidol treatment, intracisternal 6-hydroxydopamine or ventral tegmental lesions

1983 • 89 citations

Nucleus accumbens cholecystokinin (CCK) can either attenuate or potentiate amphetamine-induced locomotor activity: Evidence for rostral-caudal differences in accumbens CCK function.

1989 • 88 citations

Characterization of the binding of [3H]L-365,260: a new potent and selective brain cholecystokinin (CCK-B) and gastrin receptor antagonist radioligand.

1989 • 87 citations

Investigation of behavioral and electrophysiological responses induced by selective stimulation of CCKB receptors by using a new highly potent CCK analog, BC 264

1990 • 77 citations

Nucleus accumbens cholecystokinin (CCK) can either attenuate or potentiate amphetamine-induced locomotor activity: Evidence for rostral-caudal differences in accumbens CCK function.

1989 • 75 citations

Neurotensin and cholecystokinin microinjected into the ventral tegmental area modulate microdialysate concentrations of dopamine and metabolites in the posterior nucleus accumbens

1990 • 74 citations

Antagonists of central and peripheral behavioral actions of cholecystokinin octapeptide.

1986 • 70 citations

Cholecystokinin potentiates dopamine inhibition of mesencephalic dopamine neurons in vitro

1987 • 64 citations

Dopamine receptor elevation by cholecystokinin

1984 • 57 citations

Brain CCK-B receptors mediate the suppression of dopamine release by cholecystokinin

1989 • 53 citations

Opposite effects of sulfated cholecystokinin on DA-sensitive adenylate cyclase in two areas of the rat nucleus accumbens

1986 • 51 citations

Cholecystokinin receptors are decreased in basal ganglia and cerebral cortex of Huntington's disease

1981 • 50 citations

Does cholecystokinin colocalize with dopamine in the human substantia nigra?

1989 • 48 citations

Receptor-Receptor Interactions

1987 • 46 citations

Evidence that type A CCK receptors facilitate dopamine efflux in rat brain

1988 • 45 citations

Microinjection of cholecystokinin into the rat ventral tegmental area potentiates dopamine‐induced hypolocomotion

1989 • 40 citations

In vivo studies on the enhancement of cholecystokinin release in the rat striatum by dopamine depletion

1989 • 32 citations

Hybrid cholecystokinin (CCK) antagonists: new implications in the design and modification of CCK antagonists

1989 • 31 citations

Cholecystokinin

1988 • 24 citations

Tyrosine hydroxylase and cholecystokinin mRNA levels in the substantia nigra, ventral tegmental area, and locus ceruleus are unaffected by acute and chronic haloperidol administration

1990 • 22 citations

Does the cholecystokinin antagonist proglumide possess antipsychotic activity?

1986 • 22 citations

Cholecystokinin antagonists

1989 • 22 citations

Reduced Cholecystokinin Levels in Cerebrospinal Fluid of Parkinsonian and Schizophrenic Patients Effect of Ceruletide in Schizophreniaa

1985 • 21 citations

Centrally administered CCK-8 suppresses activity in mice by a “peripheral-type” CCK receptor

1989 • 19 citations

Effects of long-term haloperidol treatment on the responsiveness of accumbens neurons to cholecystokinin and dopamine: electrophysiological and radioligand binding studies in the rat

1990 • 18 citations

Peptide-dopamine interactions in the central nervous system: implications for neuropsychiatric disorders

1989 • 15 citations

Microdialysis as an approach to quantitate the release of neuropeptides

1990 • 12 citations

The chronic administration of dopamine antagonists and methamphetamine changed the [3H]-cholecystokinin-8 binding sites in the rat frontal cortex

1987 • 7 citations